Isolation and structural characterization of a novel polysaccharide from Hericium erinaceus fruiting bodies and its arrest of cell cycle at S-phage in colon cancer cells

Jing-Yu Liu,Xiao-Xiao Hou,Zhuo-Yu Li,Shu-Hua Shan,Ming-Chang Chang,Cui-Ping Feng,Yin Wei
DOI: https://doi.org/10.1016/j.ijbiomac.2020.04.162
IF: 8.2
2020-08-01
International Journal of Biological Macromolecules
Abstract:<p>The fruiting body of <em>Hericium erinaceus</em> has been used to treat digestive system disorder-related diseases for over 2000 years in China. A novel polysaccharide, HEFP-2b, was obtained from <em>H. erinaceus</em> fruiting bodies. Physical and chemical analysis showed that HEFP-2b consisted of fucose, galactose, glucose, and mannose in molar ratio of 11.81:22.82:44.28:21.09, and that its molecular weight was 3.252 × 10<sup>4</sup> Da. The backbone of HEFP-2b consisted of →6)-linked-α-D-Glc<em>p</em>-(1→ and →4)-β-D-Gal<em>p</em>-(1→ and →3,6) -α-D-Man<em>p</em> linkage, with two side-branching units of (1→ and →6)-β-D-Gal<em>p</em> and (1→ and →4)-α-D-Man<em>p</em>, terminated by Glc and Fuc. The results of the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and cell cycle arrest experiments revealed that HEFP-2b considerably inhibited the growth of colon cancer cells (HCT-116) <em>in vitro</em>. The growth inhibitory effects of HEFP-2b correlated with their ability to arrest the cell cycle at the <em>S</em>-phase. Our results will provide valuable information for future studies on HEFP-2b as a novel health-promoting functional food ingredient that can be used for treating colon cancer.</p>
polymer science,biochemistry & molecular biology,chemistry, applied
What problem does this paper attempt to address?